Chuansong Wang Email

VP Process Sciences . Adverum Biotechnologies

Current Roles

Employees:
177
Revenue:
$34.3M
About
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit www.adverum.com.
Adverum Biotechnologies Address
100 Cardinal Way
Redwood City, CA
United States
Adverum Biotechnologies Email

Past Companies

Adverum BiotechnologiesVice President of Process Sciences
RochePre-Clinical Operation and GLP manufacturing Leader
Spark Therapeutics, Inc.Pre-clinical Operation and GLP manufacturing Lead

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.